Waldencast Q2 2025 & Q3 2025 Trading Update Earnings Results & Report

Waldencast EPS Results

• Actual EPS: -$0.6895
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A

Waldencast Revenue Results

• Actual Revenue: $66.14 million
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

Waldencast (NASDAQ:WALD) (NASDAQ: WALD) is a global beauty and wellness platform that develops, acquires and operates consumer brands in skincare, cosmetics and related personal-care categories. The company focuses on building brands with differentiated products, strong consumer identities and distribution across multiple retail and digital channels.

Its portfolio has included Obagi Medical, a skincare brand known for dermatologist-focused products targeting concerns such as hyperpigmentation, signs of aging and acne, and Milk Makeup, a color cosmetics and skincare brand offering products designed for contemporary, on-the-go consumers. Waldencast’s brands are marketed through professional, specialty retail, department store, direct-to-consumer and e-commerce channels.

Waldencast was formed as a beauty-focused acquisition platform and became a publicly traded company following its business combination with Obagi and Milk Makeup in 2022. The company serves consumers in the United States and international markets through its retail, professional and online distribution networks. Hind Sebti, a beauty-industry executive and co-founder of Waldencast, has served as the company’s chief executive officer.